What is Custom Biologicals?
Custom Biologicals, frequently referred to as CustomBio, operates at the intersection of biotechnology and environmental sustainability. The company specializes in the development and distribution of advanced microbial products designed to address complex challenges in agriculture, bioremediation, and wastewater management. Their diverse portfolio, which includes specialized blends like Biota Max and Trichoderma-based solutions, serves a broad spectrum of clients ranging from large-scale commercial agricultural operations to individual consumer needs. Beyond its core product offerings, the firm distinguishes itself through a robust private label manufacturing model, providing bespoke biological solutions that empower distributors and service providers to meet increasing regulatory and ecological demands.
How much funding has Custom Biologicals raised?
Custom Biologicals has raised a total of $114K across 1 funding round:
Debt
$114K
Debt (2021): $114K with participation from PPP
Key Investors in Custom Biologicals
PPP
Public-Private Partnership
What's next for Custom Biologicals?
With the successful acquisition of this late-stage capital, Custom Biologicals is poised to transition into a phase of aggressive market expansion and product diversification. The strategic roadmap likely involves scaling production capacity to meet the rising demand for sustainable agricultural inputs and expanding its footprint in the wastewater treatment market. As environmental regulations tighten globally, the company's focus on effective, non-toxic biological alternatives provides a distinct competitive advantage. Future growth will likely be driven by deepening its private label partnerships and investing in R&D to refine its microbial formulations, ensuring that CustomBio remains a pivotal player in the transition toward greener industrial and agricultural practices.
See full Custom Biologicals company page
